Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications

Abstract

Abstract. Kannan RM, Nance E, Kannan S, Tomalia DA (Center for Nanomedicine; Johns Hopkins University School of Medicine, Baltimore, MD; NanoSynthons LLC, Mt. Pleasant, MI; University of Pennsylvania, Philadelphia, PA; and Virginia Commonwealth University, VA, USA). Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications (Review). J Intern Med 2014; 276: 579-617.Dendrimers are discrete nanostructures/nanoparticles with 'onion skin-like' branched layers. Beginning with a core, these nanostructures grow in concentric layers to produce stepwise increases in size that are similar to the dimensions of many in vivo globular proteins. These branched tree-like concentric layers are referred to as 'generations'. The outer generation of each dendrimer presents a precise number of functional groups that may act as a monodispersed platform for engineering favourable nanoparticle-drug and nanoparticletissue interactions. These features have attracted significant attention in medicine as nanocarriers for traditional small drugs, proteins, DNA/RNA and in some instances as intrinsically active nanoscale drugs. Dendrimer-based drugs, as well as diagnostic and imaging agents, are emerging as promising candidates for many nanomedicine applications. First, we will provide a brief survey of recent nanomedicines that are either approved or in the clinical approval process. This will be followed by an introduction to a new 'nanoperiodic' concept which proposes nanoparticle structure control and the engineering of 'critical nanoscale design parameters' (CNDPs) as a strategy for optimizing pharmocokinetics, pharmocodynamics and site-specific targeting of disease. This paradigm has led to the emergence of CNDP-directed nanoperiodic property patterns relating nanoparticle behaviour to critical in vivo clinical translation issues such as cellular uptake, transport, elimination, biodistribution, accumulation and nanotoxicology. With a focus on dendrimers, these CNDPdirected nanoperiodic patterns are used as a strategy for designing and optimizing nanoparticles for a variety of drug delivery and imaging applications, including a recent dendrimer-based theranostic nanodevice for imaging and treating cancer. Several emerging preclinical dendrimer-based nanotherapy concepts related to inflammation, neuro-inflammatory disorders, oncology and infectious and ocular diseases are reviewed. Finally we will consider challenges and opportunities anticipated for future clinical translation, nanotoxicology and the commercialization of nanomedicine.

Multi-Target Inhibition of Cancer Cell Growth by SiRNA Cocktails and 5-Fluorouracil Using Effective Piperidine-Terminated Phosphorus Dendrimers

“…Dendrimers, a class of nanoscale hyperbranched polymers with radial symmetry, represent one of the most promising tools for delivering of therapeutic genetic material into cancer cells [4][5][6][7]. Their well-defined structure with multivalent surface groups being, for instance, positively charged allows siRNAs to bind to them, thereby forming stable complexes called dendriplexes.…”

Advances in the application of nanotechnology in the diagnosis and treatment of gastrointestinal tumors

“…The shape, size, surface functionalities and branching length of a dendrimer may be manipulated to perform different functions (50,51). The diameters of dendrimers range between 1 and 10 nm.…”

Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications

“…2 Dendrimers (from the Greek Dendron meaning tree), are discrete nanoparticles with "onion skin-like" branched layers. 2,3 Dendrimers are defined as synthetic macromolecules characterized by a large number of branching points, a threedimensional globular shape, monodispersity, and nanometric size range. Their three-dimensional structure has a significant impact on their physical and chemical properties.…”